Cite
HARVARD Citation
Strüßmann, T. et al. (2022). A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin. Leukemia & lymphoma. 63 (9), pp. 2260-2262. [Online].